This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Johnson, A. J.
Right arrow Articles by Roehrig, J. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Johnson, A. J.
Right arrow Articles by Roehrig, J. T.

 Previous Article  |  Next Article 

Journal of Virology, January 1999, p. 783-786, Vol. 73, No. 1
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.

New Mouse Model for Dengue Virus Vaccine Testing

Alison J. Johnson* and John T. Roehrig

Division of Vector-Borne Infectious Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Public Health Service, United States Department of Health and Human Services, Fort Collins, Colorado 80522

Received 13 July 1998/Accepted 7 October 1998

Several dengue (DEN) virus vaccines are in development; however, the lack of a reliable small animal model in which to test them is a major obstacle. Because evidence suggests that interferon (IFN) is involved in the human anti-DEN virus response, we tested mice deficient in their IFN functions as potential models. Intraperitoneally administered mouse-adapted DEN 2 virus was uniformly lethal in AG129 mice (which lack alpha/beta IFN and gamma IFN receptor genes), regardless of age. Immunized mice were protected from virus challenge, and survival times increased following passive transfer of anti-DEN polyclonal antibody. These results demonstrate that AG129 mice are a promising small animal model for DEN virus vaccine trials.

* Corresponding author. Mailing address: DVBID, Centers for Disease Control and Prevention, P. O. Box 2087, Fort Collins, CO 80522. Phone: (970) 221-6469. Fax: (970) 221-6476. E-mail: ajj1{at}cdc.gov.

Journal of Virology, January 1999, p. 783-786, Vol. 73, No. 1
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:

  • Souza, D. G., Fagundes, C. T., Sousa, L. P., Amaral, F. A., Souza, R. S., Souza, A. L., Kroon, E. G., Sachs, D., Cunha, F. Q., Bukin, E., Atrasheuskaya, A., Ignatyev, G., Teixeira, M. M. (2009). Essential role of platelet-activating factor receptor in the pathogenesis of Dengue virus infection. Proc. Natl. Acad. Sci. USA 106: 14138-14143 [Abstract] [Full Text]  
  • Perry, S. T., Prestwood, T. R., Lada, S. M., Benedict, C. A., Shresta, S. (2009). Cardif-Mediated Signaling Controls the Initial Innate Response to Dengue Virus In Vivo. J. Virol. 83: 8276-8281 [Abstract] [Full Text]  
  • Kamau, E., Takhampunya, R., Li, T., Kelly, E., Peachman, K. K., Lynch, J. A., Sun, P., Palmer, D. R. (2009). Dengue virus infection promotes translocation of high mobility group box 1 protein from the nucleus to the cytosol in dendritic cells, upregulates cytokine production and modulates virus replication. J. Gen. Virol. 90: 1827-1835 [Abstract] [Full Text]  
  • Weatherford, T., Chavez, D., Brasky, K. M., Lanford, R. E. (2009). The Marmoset Model of GB Virus B Infections: Adaptation to Host Phenotypic Variation. J. Virol. 83: 5806-5814 [Abstract] [Full Text]  
  • Yauch, L. E., Zellweger, R. M., Kotturi, M. F., Qutubuddin, A., Sidney, J., Peters, B., Prestwood, T. R., Sette, A., Shresta, S. (2009). A Protective Role for Dengue Virus-Specific CD8+ T Cells. J. Immunol. 182: 4865-4873 [Abstract] [Full Text]  
  • Balsitis, S. J., Coloma, J., Castro, G., Alava, A., Flores, D., McKerrow, J. H., Beatty, P. R., Harris, E. (2009). Tropism of Dengue Virus in Mice and Humans Defined by Viral Nonstructural Protein 3-Specific Immunostaining. Am J Trop Med Hyg 80: 416-424 [Abstract] [Full Text]  
  • Suzuki, R., Winkelmann, E. R., Mason, P. W. (2009). Construction and Characterization of a Single-Cycle Chimeric Flavivirus Vaccine Candidate That Protects Mice against Lethal Challenge with Dengue Virus Type 2. J. Virol. 83: 1870-1880 [Abstract] [Full Text]  
  • Stein, D. A., Huang, C. Y.-H., Silengo, S., Amantana, A., Crumley, S., Blouch, R. E., Iversen, P. L., Kinney, R. M. (2008). Treatment of AG129 mice with antisense morpholino oligomers increases survival time following challenge with dengue 2 virus. J Antimicrob Chemother 62: 555-565 [Abstract] [Full Text]  
  • Prestwood, T. R., Prigozhin, D. M., Sharar, K. L., Zellweger, R. M., Shresta, S. (2008). A Mouse-Passaged Dengue Virus Strain with Reduced Affinity for Heparan Sulfate Causes Severe Disease in Mice by Establishing Increased Systemic Viral Loads. J. Virol. 82: 8411-8421 [Abstract] [Full Text]  
  • Silva, M. C., Guerrero-Plata, A., Gilfoy, F. D., Garofalo, R. P., Mason, P. W. (2007). Differential Activation of Human Monocyte-Derived and Plasmacytoid Dendritic Cells by West Nile Virus Generated in Different Host Cells. J. Virol. 81: 13640-13648 [Abstract] [Full Text]  
  • Oliphant, T., Nybakken, G. E., Austin, S. K., Xu, Q., Bramson, J., Loeb, M., Throsby, M., Fremont, D. H., Pierson, T. C., Diamond, M. S. (2007). Induction of Epitope-Specific Neutralizing Antibodies against West Nile Virus. J. Virol. 81: 11828-11839 [Abstract] [Full Text]  
  • Gilfoy, F. D., Mason, P. W. (2007). West Nile Virus-Induced Interferon Production Is Mediated by the Double-Stranded RNA-Dependent Protein Kinase PKR. J. Virol. 81: 11148-11158 [Abstract] [Full Text]  
  • Bourne, N., Scholle, F., Silva, M. C., Rossi, S. L., Dewsbury, N., Judy, B., De Aguiar, J. B., Leon, M. A., Estes, D. M., Fayzulin, R., Mason, P. W. (2007). Early Production of Type I Interferon during West Nile Virus Infection: Role for Lymphoid Tissues in IRF3-Independent Interferon Production. J. Virol. 81: 9100-9108 [Abstract] [Full Text]  
  • Chen, H.-C., Hofman, F. M., Kung, J. T., Lin, Y.-D., Wu-Hsieh, B. A. (2007). Both Virus and Tumor Necrosis Factor Alpha Are Critical for Endothelium Damage in a Mouse Model of Dengue Virus-Induced Hemorrhage. J. Virol. 81: 5518-5526 [Abstract] [Full Text]  
  • Oliphant, T., Nybakken, G. E., Engle, M., Xu, Q., Nelson, C. A., Sukupolvi-Petty, S., Marri, A., Lachmi, B.-E., Olshevsky, U., Fremont, D. H., Pierson, T. C., Diamond, M. S. (2006). Antibody Recognition and Neutralization Determinants on Domains I and II of West Nile Virus Envelope Protein. J. Virol. 80: 12149-12159 [Abstract] [Full Text]  
  • Clyde, K., Kyle, J. L., Harris, E. (2006). Recent Advances in Deciphering Viral and Host Determinants of Dengue Virus Replication and Pathogenesis. J. Virol. 80: 11418-11431 [Full Text]  
  • Lee, E., Wright, P. J., Davidson, A., Lobigs, M. (2006). Virulence attenuation of Dengue virus due to augmented glycosaminoglycan-binding affinity and restriction in extraneural dissemination.. J. Gen. Virol. 87: 2791-2801 [Abstract] [Full Text]  
  • Shresta, S., Sharar, K. L., Prigozhin, D. M., Beatty, P. R., Harris, E. (2006). Murine Model for Dengue Virus-Induced Lethal Disease with Increased Vascular Permeability.. J. Virol. 80: 10208-10217 [Abstract] [Full Text]  
  • Shrestha, B., Wang, T., Samuel, M. A., Whitby, K., Craft, J., Fikrig, E., Diamond, M. S. (2006). Gamma Interferon Plays a Crucial Early Antiviral Role in Protection against West Nile Virus Infection.. J. Virol. 80: 5338-5348 [Abstract] [Full Text]  
  • Calvert, A. E., Huang, C. Y.-H., Kinney, R. M., Roehrig, J. T. (2006). Non-structural proteins of dengue 2 virus offer limited protection to interferon-deficient mice after dengue 2 virus challenge. J. Gen. Virol. 87: 339-346 [Abstract] [Full Text]  
  • Shinozaki, K., Ebert, O., Suriawinata, A., Thung, S. N., Woo, S. L. C. (2005). Prophylactic Alpha Interferon Treatment Increases the Therapeutic Index of Oncolytic Vesicular Stomatitis Virus Virotherapy for Advanced Hepatocellular Carcinoma in Immune-Competent Rats. J. Virol. 79: 13705-13713 [Abstract] [Full Text]  
  • Bente, D. A., Melkus, M. W., Garcia, J. V., Rico-Hesse, R. (2005). Dengue Fever in Humanized NOD/SCID Mice. J. Virol. 79: 13797-13799 [Abstract] [Full Text]  
  • Whitby, K., Pierson, T. C., Geiss, B., Lane, K., Engle, M., Zhou, Y., Doms, R. W., Diamond, M. S. (2005). Castanospermine, a Potent Inhibitor of Dengue Virus Infection In Vitro and In Vivo. J. Virol. 79: 8698-8706 [Abstract] [Full Text]  
  • Ho, L.-J., Hung, L.-F., Weng, C.-Y., Wu, W.-L., Chou, P., Lin, Y.-L., Chang, D.-M., Tai, T.-Y., Lai, J.-H. (2005). Dengue Virus Type 2 Antagonizes IFN-{alpha} but Not IFN-{gamma} Antiviral Effect via Down-Regulating Tyk2-STAT Signaling in the Human Dendritic Cell. J. Immunol. 174: 8163-8172 [Abstract] [Full Text]  
  • Jones, M., Davidson, A., Hibbert, L., Gruenwald, P., Schlaak, J., Ball, S., Foster, G. R., Jacobs, M. (2005). Dengue Virus Inhibits Alpha Interferon Signaling by Reducing STAT2 Expression. J. Virol. 79: 5414-5420 [Abstract] [Full Text]  
  • Lin, R.-J., Liao, C.-L., Lin, E., Lin, Y.-L. (2004). Blocking of the Alpha Interferon-Induced Jak-Stat Signaling Pathway by Japanese Encephalitis Virus Infection. J. Virol. 78: 9285-9294 [Abstract] [Full Text]  
  • Shresta, S., Kyle, J. L., Snider, H. M., Basavapatna, M., Beatty, P. R., Harris, E. (2004). Interferon-Dependent Immunity Is Essential for Resistance to Primary Dengue Virus Infection in Mice, Whereas T- and B-Cell-Dependent Immunity Are Less Critical. J. Virol. 78: 2701-2710 [Abstract] [Full Text]  
  • GWINN, W., SUN, W., INNIS, B. L., CAUDILL, J., KING, A. D. (2003). SEROTYPE-SPECIFIC TH1 RESPONSES IN RECIPIENTS OF TWO DOSES OF CANDIDATE LIVE-ATTENUATED DENGUE VIRUS VACCINES. Am J Trop Med Hyg 69: 39-47 [Abstract] [Full Text]  
  • Huang, C. Y.-H., Butrapet, S., Tsuchiya, K. R., Bhamarapravati, N., Gubler, D. J., Kinney, R. M. (2003). Dengue 2 PDK-53 Virus as a Chimeric Carrier for Tetravalent Dengue Vaccine Development. J. Virol. 77: 11436-11447 [Abstract] [Full Text]  
  • Chambers, T. J., Nickells, M. (2001). Neuroadapted Yellow Fever Virus 17D: Genetic and Biological Characterization of a Highly Mouse-Neurovirulent Virus and Its Infectious Molecular Clone. J. Virol. 75: 10912-10922 [Abstract] [Full Text]  
  • Samuel, C. E. (2001). Antiviral Actions of Interferons. Clin. Microbiol. Rev. 14: 778-809 [Abstract] [Full Text]  
  • Goodbourn, S., Didcock, L., Randall, R. E. (2000). Interferons: cell signalling, immune modulation, antiviral response and virus countermeasures. J. Gen. Virol. 81: 2341-2364 [Full Text]  
  • Huang, K.-J., Li, S.-Y. J., Chen, S.-C., Liu, H.-S., Lin, Y.-S., Yeh, T.-M., Liu, C.-C., Lei, H.-Y. (2000). Manifestation of thrombocytopenia in dengue-2-virus-infected mice. J. Gen. Virol. 81: 2177-2182 [Abstract] [Full Text]  
  • Diamond, M. S., Roberts, T. G., Edgil, D., Lu, B., Ernst, J., Harris, E. (2000). Modulation of Dengue Virus Infection in Human Cells by Alpha, Beta, and Gamma Interferons. J. Virol. 74: 4957-4966 [Abstract] [Full Text]  
  • Leyssen, P., De Clercq, E., Neyts, J. (2000). Perspectives for the Treatment of Infections with Flaviviridae. Clin. Microbiol. Rev. 13: 67-82 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»